PBPK modeling

0:20:08

1 Introduction to PBPK Modeling

0:03:39

Common Myths about PBPK Modeling and Simulation- Busted!

0:34:35

Introduction to PBPK Modeling for Chemical Risk Assessment

0:03:18

The benefits of using Pharmacokinetic and Pharmacodynamic modeling

0:10:03

Introduction to PBPK modeling with PK-Sim 6

0:49:40

PBPK modeling and simulation: Bridging the “Bottom Up” and “Top-Down” Approaches

0:20:32

A physiologically based pharmacokinetic (PBPK) model of pravastatin

0:40:57

Precision Dosing Using PBPK Modeling

0:01:52

PBPK modeling supports approval of breakthrough cancer drug

0:02:12

a prototype of PBPK modeling & simulation

0:12:59

3 Introduction to DDI for PBPK Modeling

0:59:23

First-In-Human (FIH) faster: The Power of Physiologically Based Pharmacokinetic (PBPK) Modeling

0:11:57

GastroPlus Tutorial: Pregnancy PBPK Modeling

0:01:06

Discover the next level in PBPK modeling with GPX™

0:05:55

PBPK model for CNS

0:19:56

PBPK to Guide Study Design and Product Development for Generic Dermatological Products

0:55:39

A Best Practice Framework for Applying PBPK Modeling to Pediatric Drug Development

0:06:38

The Use of PBPK modeling in Drug Discovery

0:36:18

Use of PBPK Modeling in In Vitro to In Vivo Extrapolation (IVIVE)

0:58:18

Unlocking the Power of PBPK Modeling: PBPK for First-in-Human and Beyond

1:23:40

Applications of GastroPlus PBPK Modeling at the FDA Office of Generic Drugs

1:17:25

GastroPlus® “Workshop from Home” April 17 PBPK PD modeling course with Haiying Zhou

0:19:14

IVIVE-PBPK Modeling for Inhalation Toxicity Testing

1:03:02

PBPK Modeling for Identifying and Mitigating Absorption Risks in Early Drug Development